{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:30Z","timestamp":1786480230446,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,9]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Overall, steroid exposure was not associated with GFR at follow-up.<\/jats:p>\n <\/jats:list-item>\n \n Hydrocortisone duration of 1\u20137 days had 2.8 times increased odds of reduced GFR at 24-month corrected age.<\/jats:p>\n <\/jats:list-item>\n \n Dexamethasone given at \u226425 weeks postmenstrual age had 9.4 times increased odds of reduced GFR compared with those given dexamethasone at \u226529 weeks.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Preterm birth is associated with low nephron endowment, with an increased risk of CKD later in life. Almost all pregnant women at risk for preterm delivery are given antenatal corticosteroids to accelerate lung maturity in preterm neonates. Similar to antenatal steroids, postnatal corticosteroids are also given to improve lung function, but the effect on kidney function is unknown. The objective of this study was to determine if duration and timing of postnatal corticosteroids in preterm infants influences kidney function at 24-month corrected age.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n A secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (neonates <28 weeks' gestation) was performed and included surviving participants with serum creatinine measured at 22\u201326 months corrected gestational age. Exposure included the presence, type, start date, and duration of postnatal steroids (duration and start date based on postmenstrual age). The primary outcome was reduced eGFR (GFR<90 ml\/min per 1.73 m\n 2<\/jats:sup>\n at the 24-month corrected gestational age time point). Outcomes were adjusted for perinatal\/neonatal exposures, and neonatal outcomes were compared.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 838 surviving infants, 397 (47%) were exposed to any postnatal steroid. Dexamethasone was the most common exposure (\n n<\/jats:italic>\n =238, median start date at day of life 27, median duration of 8 days), followed by hydrocortisone (\n n<\/jats:italic>\n =232, median start day of life 13, median duration 17 days). In total, 348 infants were evaluated at the 22\u201326-month follow-up, 61 of whom had reduced GFR. Hydrocortisone duration of 1\u20137 days had 2.8 (95% confidence interval, 1.06 to 7.62) times increased odds of reduced GFR at 24-month corrected age. Although overall steroid exposure was not associated with GFR at follow-up, initiation of dexamethasone at \u226425 weeks postmenstrual age was associated with 9.39 (95% confidence interval, 1.61 to 54.71) increased odds of reduced GFR compared with those given dexamethasone at \u226529 weeks.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Although observational, this study supports an association between postnatal steroid timing, duration, and reduced GFR. Further studies are warranted to better understand this association to protect long-term kidney health.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000000824","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T12:00:34Z","timestamp":1745236834000},"page":"1491-1500","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Postnatal Steroid Exposure in Extremely Low Gestational Age Newborns and Kidney Function at 24 Months Corrected Age"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-8138","authenticated-orcid":false,"given":"Meredith P.","family":"Schuh","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5004-7996","authenticated-orcid":false,"given":"Russel","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, The University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4880-9792","authenticated-orcid":false,"given":"Cara","family":"Slagle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-0760","authenticated-orcid":false,"given":"David","family":"Selewski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7019-809X","authenticated-orcid":false,"given":"Danielle E.","family":"Soranno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9349-9960","authenticated-orcid":false,"given":"Megan J.","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8688-8770","authenticated-orcid":false,"given":"Jennifer","family":"Varner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6840-9887","authenticated-orcid":false,"given":"David","family":"Askenazi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8473-0307","authenticated-orcid":false,"given":"Shina","family":"Menon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7427-670X","authenticated-orcid":false,"given":"Katja M.","family":"Gist","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"6","key":"B1-20251006","first-page":"777","article-title":"Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and Cavalieri principle","volume":"64","author":"Hinchliffe","year":"1991","journal-title":"Lab Invest."},{"issue":"7","key":"B2-20251006","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1681\/ASN.2010121266","article-title":"Accelerated maturation and abnormal morphology in the preterm neonatal kidney","volume":"22","author":"Sutherland","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B3-20251006","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ekir.2023.10.032","article-title":"Human nephrogenesis can persist beyond 40 postnatal days in preterm infants","volume":"9","author":"Carpenter","year":"2024","journal-title":"Kidney Int Rep."},{"issue":"4 Pt 1","key":"B4-20251006","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ajh\/1.4.335","article-title":"Glomeruli and blood pressure. Less of one, more the other?","volume":"1","author":"Brenner","year":"1988","journal-title":"Am J Hypertens."},{"issue":"9888","key":"B5-20251006","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(13)60311-6","article-title":"Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease","volume":"382","author":"Luyckx","year":"2013","journal-title":"Lancet."},{"key":"B6-20251006","doi-asserted-by":"crossref","first-page":"l1346","DOI":"10.1136\/bmj.l1346","article-title":"Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study","volume":"365","author":"Crump","year":"2019","journal-title":"BMJ."},{"issue":"2","key":"B7-20251006","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.ajkd.2008.12.042","article-title":"Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies","volume":"54","author":"White","year":"2009","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B8-20251006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2007020252","article-title":"Low birth weight increases risk for end-stage renal disease","volume":"19","author":"Vikse","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"B9-20251006","doi-asserted-by":"crossref","first-page":"e2233331","DOI":"10.1001\/jamanetworkopen.2022.33331","article-title":"Association of antenatal steroid exposure at 21 to 22 weeks of gestation with neonatal survival and survival without morbidities","volume":"5","author":"Chawla","year":"2022","journal-title":"JAMA Netw Open."},{"issue":"6","key":"B10-20251006","doi-asserted-by":"crossref","first-page":"F1668","DOI":"10.1152\/ajprenal.00163.2009","article-title":"Is nephrogenesis affected by preterm birth? Studies in a non-human primate model","volume":"297","author":"Gubhaju","year":"2009","journal-title":"Am J Physiol Renal Physiol."},{"key":"B11-20251006","first-page":"Cd004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"12","author":"McGoldrick","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"B12-20251006","doi-asserted-by":"crossref","first-page":"F548","DOI":"10.1152\/ajprenal.00156.2007","article-title":"Effects of dexamethasone exposure on rat metanephric development: in vitro and in vivo studies","volume":"293","author":"Singh","year":"2007","journal-title":"Am J Physiol Ren Physiol."},{"issue":"5 Pt 1","key":"B13-20251006","first-page":"871","article-title":"ACOG Committee opinion: antenatal corticosteroid therapy for fetal maturation","volume":"99","year":"2002","journal-title":"Obstet Gynecol."},{"issue":"5","key":"B14-20251006","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1046\/j.1523-1755.2001.0590051663.x","article-title":"Effect of prenatal dexamethasone on rat renal development","volume":"59","author":"Ortiz","year":"2001","journal-title":"Kidney Int."},{"issue":"5","key":"B15-20251006","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2020101459","article-title":"The rhesus macaque serves as a model for human lateral branch nephrogenesis","volume":"32","author":"Schuh","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"8338","key":"B16-20251006","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(83)92139-6","article-title":"Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia","volume":"1","author":"Mammel","year":"1983","journal-title":"Lancet."},{"issue":"1","key":"B17-20251006","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clp.2008.09.016","article-title":"Postnatal corticosteroids for bronchopulmonary dysplasia","volume":"36","author":"Jobe","year":"2009","journal-title":"Clin Perinatol."},{"issue":"7","key":"B18-20251006","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41390-021-01624-1","article-title":"Postnatal glucocorticoid use impacts renal function in VLBW neonates","volume":"91","author":"Mhanna","year":"2022","journal-title":"Pediatr Res."},{"issue":"3","key":"B19-20251006","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","author":"Juul","year":"2020","journal-title":"N Engl J Med."},{"issue":"4","key":"B20-20251006","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/pr.2017.136","article-title":"Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop","volume":"82","author":"Zappitelli","year":"2017","journal-title":"Pediatr Res."},{"issue":"4","key":"B21-20251006","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract."},{"issue":"3","key":"B22-20251006","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S2352-4642(17)30069-X","article-title":"Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study","volume":"1","author":"Jetton","year":"2017","journal-title":"Lancet Child Adolesc Health."},{"issue":"8","key":"B23-20251006","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2215\/CJN.15011121","article-title":"Prevalence and risk factors for kidney disease and elevated BP in 2-year-old children born extremely premature","volume":"17","author":"Hingorani","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B24-20251006","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/pch\/pxaa073","article-title":"Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants","volume":"25","author":"Lemyre","year":"2020","journal-title":"Paediatr Child Health."},{"issue":"5","key":"B25-20251006","first-page":"Cd001146","article-title":"Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants","author":"Doyle","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"B26-20251006","first-page":"Cd001145","article-title":"Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"10","author":"Doyle","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"B27-20251006","doi-asserted-by":"crossref","first-page":"e206826","DOI":"10.1001\/jamapediatrics.2020.6826","article-title":"Assessment of postnatal corticosteroids for the prevention of bronchopulmonary dysplasia in preterm neonates: a systematic review and network meta-analysis","volume":"175","author":"Ramaswamy","year":"2021","journal-title":"JAMA Pediatr."},{"issue":"12","key":"B28-20251006","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa2114897","article-title":"Hydrocortisone to improve survival without bronchopulmonary dysplasia","volume":"386","author":"Watterberg","year":"2022","journal-title":"N Engl J Med."},{"issue":"8","key":"B29-20251006","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s41372-021-01083-w","article-title":"Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia","volume":"41","author":"Htun","year":"2021","journal-title":"J Perinatol."},{"issue":"10030","key":"B30-20251006","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(16)00202-6","article-title":"Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial","volume":"387","author":"Baud","year":"2016","journal-title":"Lancet."},{"issue":"1","key":"B31-20251006","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther."},{"issue":"1-2","key":"B32-20251006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbamem.2004.01.006","article-title":"Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage","volume":"1663","author":"Cevc","year":"2004","journal-title":"Biochim Biophys Acta."},{"issue":"1","key":"B33-20251006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.kisu.2021.11.004","article-title":"Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease","volume":"12","author":"Nakamura","year":"2022","journal-title":"Kidney Int Suppl (2011)."},{"issue":"1","key":"B34-20251006","doi-asserted-by":"crossref","first-page":"e0145946","DOI":"10.1371\/journal.pone.0145946","article-title":"Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats","volume":"11","author":"Mart\u00edn-Fern\u00e1ndez","year":"2016","journal-title":"PLoS One."},{"issue":"3","key":"B35-20251006","doi-asserted-by":"crossref","first-page":"e221947","DOI":"10.1001\/jamanetworkopen.2022.1947","article-title":"Dexamethasone, prednisolone, and methylprednisolone use and 2-year neurodevelopmental outcomes in extremely preterm infants","volume":"5","author":"Puia-Dumitrescu","year":"2022","journal-title":"JAMA Netw Open."},{"issue":"12","key":"B36-20251006","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1055\/s-0040-1722330","article-title":"Antenatal steroids and acute kidney injury in preterm infants","volume":"39","author":"\u00dcst\u00fcn","year":"2022","journal-title":"Am J Perinatol."},{"issue":"12","key":"B37-20251006","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41372-024-02011-4","article-title":"Post-natal steroid exposure in very low birthweight neonates and associations with acute kidney injury","volume":"44","author":"Coleman","year":"2024","journal-title":"J Perinatol."},{"issue":"2","key":"B38-20251006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.jp.7211193","article-title":"A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants","volume":"25","author":"Efird","year":"2005","journal-title":"J Perinatol."},{"issue":"12","key":"B39-20251006","first-page":"Cd003662","article-title":"Corticosteroids for treating hypotension in preterm infants","volume":"2011","author":"Ibrahim","year":"2011","journal-title":"Cochrane Database Syst Rev."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:58:54Z","timestamp":1786478334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000824","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"2025-01-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}